Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma.

MLA

Gabriel, Emmanuel M., et al. “Expression of C-Erb-B2 Oncoprotein as a Neoantigen Strategy to Repurpose Anti-Neu Antibody Therapy in a Model of Melanoma.” Scientific Reports, vol. 14, no. 1, Oct. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41598-024-76209-z.

APA

Gabriel, E. M., Necela, B., Bahr, D., Vivekanandhan, S., Shreeder, B., Bagaria, S., & Knutson, K. L. (2024). Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma. Scientific Reports, 14(1), 1–13. https://doi.org/10.1038/s41598-024-76209-z

Chicago

Gabriel, Emmanuel M., Brian Necela, Deborah Bahr, Sneha Vivekanandhan, Barath Shreeder, Sanjay Bagaria, and Keith L. Knutson. 2024. “Expression of C-Erb-B2 Oncoprotein as a Neoantigen Strategy to Repurpose Anti-Neu Antibody Therapy in a Model of Melanoma.” Scientific Reports 14 (1): 1–13. doi:10.1038/s41598-024-76209-z.